Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients-Reference-Cited by-同舟云学术

Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients

Published:2013-12-07 Issue:3 Volume:93 Page:479-484
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

König C.,Kleber M.,Reinhardt H.,Knop S.,Wäsch R.,Engelhardt M.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-013-1951-6.pdf

Reference14 articles.

1. Mikhael JR, Dingli D, Roy V, Reeder CB, Buadi FK, Hayman SR, Dispenzieri A, Fonseca R, Sher T, Kyle RA, Lin Y, Russell SJ, Kumar S, Bergsagel PL, Zeldenrust SR, Leung N, Drake MT, Kapoor P, Ansell SM, Witzig TE, Lust JA, Dalton RJ, Gertz MA, Stewart K, Rajkumar SV, Chanan-Khan A, Lacy MQ (2013) Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013. Mayo Clin Proc 88(4):360–376

2. Kleber M, Ihorst G, Terhorst M, Koch B, Deschler B, Wasch R, Engelhardt M (2011) Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity score. Blood Cancer J 1(9):e35

3. Kleber M, Ihorst G, Gross B, Koch B, Reinhardt H, Wasch R, Engelhardt M (2013) Validation of the Freiburg Comorbidity Index in 466 Multiple Myeloma Patients and Combination With the International Staging System Are Highly Predictive for Outcome. Clin Lymphoma Myeloma Leuk

4. Chanan-Khan A, Sonneveld P, Schuster MW, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, Neuwirth R, Anderson KC, Richardson PG (2008) Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study. J Clin Oncol 26(29):4784–4790

5. Dasanu CA, Alexandrescu DT (2009) Does bortezomib induce de facto varicella zoster virus reactivation in patients with multiple myeloma? J Clin Oncol 27(13):2293–2294, author reply 2294–2296

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral Encephalitis after Hematopoietic Cell Transplantation: A Systematic Review;Transplantation and Cellular Therapy;2023-10

2. First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium;Clinical Lymphoma Myeloma and Leukemia;2023-05

3. How can an immunologist influence the occurrence of secondary infections in breast cancer? Real‑life study;Bratislava Medical Journal;2023

4. Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study;European Journal of Cancer;2022-11

5. Das Multiples Myelom: Pflege entlang der Krankheitsverlaufskurve;TumorDiagnostik & Therapie;2022-11